© 2020 MJH Life Sciences and Dermatology Times. All rights reserved.
June 23, 2020
Gusacitinib, an investigational oral Janus kinase/spleen tyrosine kinase inhibitor, demonstrated statistical superiority compared with placebo for improving chronic hand eczema in a phase 2b study.
December 07, 2017
A retrospective review of pediatric patients treated for psoriasis with systemic agents provides much needed insight about the safety and tolerability of these medications.
May 09, 2016
Two novel energy-based approaches are ushering in a new era in acne treatment. One expert addresses the role these devices may play.
April 12, 2016
New findings support dietary and supplementation practices that can influence acne. One expert discusses modifications in context of protocols for managing the condition.